Contec Medical Systems Co.,Ltd (SHE:300869)

SHE:300869 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Cash & Equivalents	982.57	982.72	684.31	470.53	1,393	623.98
Short-Term Investments	-	411.74	252.03	840.82	486.27	189.98
Trading Asset Securities	832.31	631.77	171.59	652.02	46.64	-
Cash & Short-Term Investments	1,815	2,026	1,108	1,963	1,926	813.96
Cash Growth	-9.92%	82.89%	-43.57%	1.96%	136.57%	-0.01%
Accounts Receivable	47.39	50.05	46	39.86	160.75	66.21
Other Receivables	18.66	7.08	7.34	7.09	13.76	39.88
Receivables	66.04	72.51	533.58	46.96	174.52	106.09
Inventory	224.31	229.58	272.32	463.23	430.24	418.69
Prepaid Expenses	-	7.87	1.21	1.78	1.42	4.08
Other Current Assets	49.45	7.55	6.18	6.83	26.64	9.31
Total Current Assets	2,155	2,344	1,921	2,482	2,558	1,352
Property, Plant & Equipment	300.8	309.13	336.07	290.76	275.13	226.09
Long-Term Investments	-	-	403.95	360.47	298.04	1,156
Other Intangible Assets	47.64	49.7	52.07	54.74	57.47	33.61
Long-Term Deferred Tax Assets	9.05	7.13	3.78	5.8	1.81	0.73
Long-Term Deferred Charges	0.03	0.05	0.07	-	-	-
Other Long-Term Assets	59.24	61.44	8.36	18	541.93	20.63
Total Assets	2,571	2,771	2,726	3,212	3,733	2,789

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Accounts Payable	31.65	11.47	18.39	17.79	54.3	47.62
Accrued Expenses	11.79	12.93	12.93	15.68	32.69	15.95
Short-Term Debt	45	215	60	347	903.37	800.39
Current Portion of Leases	-	1.08	1.42	3.16	1.67	1.15
Current Income Taxes Payable	0.69	1.46	0.24	26.1	18.81	37.65
Current Unearned Revenue	33.33	30.63	32.04	39.97	76.6	45.61
Other Current Liabilities	4.54	6.93	9.78	10.25	25.11	7.27
Total Current Liabilities	127	279.5	134.79	459.94	1,113	955.64
Long-Term Debt	762.65	749.14	723.52	695.57	666.94	-
Long-Term Leases	1.21	2.26	1.83	2.72	4.06	2.79
Long-Term Unearned Revenue	6.55	7.09	7.81	8.92	9.07	9.76
Long-Term Deferred Tax Liabilities	0.07	0.06	0.15	0	11.85	0.8
Total Liabilities	897.47	1,038	868.1	1,167	1,804	968.99

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Common Stock	401.8	401.8	401.8	401.8	401.8	401.8
Additional Paid-In Capital	-	352.35	352.34	345.14	344.98	344.98
Retained Earnings	884.71	941.99	1,067	1,265	1,150	1,074
Comprehensive Income & Other	387.45	37.01	36.41	32.54	31.79	-0.82
Shareholders' Equity	1,674	1,733	1,857	2,045	1,928	1,820
Total Liabilities & Equity	2,571	2,771	2,726	3,212	3,733	2,789

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Total Debt	808.86	967.48	786.77	1,048	1,576	804.33
Net Cash (Debt)	1,006	1,059	321.15	914.91	349.56	9.63
Net Cash Growth	-6.34%	229.68%	-64.90%	161.73%	3529.53%	-98.24%
Net Cash Per Share	2.47	2.60	0.78	2.21	0.86	0.02
Filing Date Shares Outstanding	383.97	401.8	401.8	401.8	401.8	401.8
Total Common Shares Outstanding	383.97	401.8	401.8	401.8	401.8	401.8
Working Capital	2,028	2,064	1,786	2,022	1,446	396.5
Book Value Per Share	4.36	4.31	4.62	5.09	4.80	4.53
Tangible Book Value	1,626	1,683	1,805	1,990	1,871	1,786
Tangible Book Value Per Share	4.24	4.19	4.49	4.95	4.66	4.45
Buildings	-	182.08	245.65	226.46	232.82	142.81
Machinery	-	199.15	181.12	169.29	147.98	125.88
Construction In Progress	-	102.3	72.85	24.55	1.32	51.22

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error